Thursday 25 October 2012

Scientists Harness Immune System To Prevent Lymphoma Relapse

UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body's own immune system, after highly promising early laboratory results. The University of Manchester researchers, who were funded by the charity Leukaemia & Lymphoma Research, with additional funding from Cancer Research UK, have shown that when used in conjunction with radiotherapy, the new drug is potentially four times more likely to lead to long-term survival than radiotherapy alone... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment